Your session is about to expire
← Back to Search
Sildenafil citrate for Pulmonary Hypertension
Study Summary
This trial is investigating the safety and effectiveness of sildenafil therapy for PH in neonates with CDH.
- Pulmonary Hypertension
- Congenital Diaphragmatic Hernia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are being included in this research project?
"Affirmative. According to the details posted on clinicaltrials.gov, this medical research is actively enrolling patients since September 15th 2022 and was last updated 27 days later. The trial seeks 40 participants from one specified location."
Has the Food and Drug Administration green-lighted Sildenafil citrate?
"There is some evidence of Sildenafil citrate's safety, so it has been assigned a value of 2 on the scale. However, as this clinical trial is in Phase 2 there are no findings that demonstrate efficacy yet."
Is this research endeavor actively searching for participants?
"This clinical experiment is presently looking for study participants, with the original post date being on September 15th 2022 and last update taking place on September 27th of the same year."
Share this study with friends
Copy Link
Messenger